EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Peptide Drug Discovery And Development Translational Research In Academia And Industry 1st Edition Miguel Castanho

SKU: BELL-2359366

$ 31.00 ~~$ 45.00~~ (-31%)

4.3

88 reviews

Peptide Drug Discovery And Development Translational Research In Academia And Industry 1st Edition Miguel Castanho instant download after payment.

Publisher: Wiley-VCH

File Extension: PDF

File size: 3.48 MB

Pages: 375

Author: Miguel Castanho, Nuno Santos

ISBN: 9783527328918, 3527328912

Language: English

Year: 2011

Edition: 1

Product desciption

Peptide Drug Discovery And Development Translational Research In Academia And Industry 1st Edition Miguel Castanho by Miguel Castanho, Nuno Santos 9783527328918, 3527328912 instant download after payment.

Filling a real knowledge gap, this handbook and ready reference is both modern and forward-looking in its emphasis on the "bench to bedside" translational approach to drug development.Clearly structured into three major parts, the book stakes out the boundaries of peptide drug development in the preclinical as well as clinical stages. The first part provides a general background and focuses on the characteristic strengths and weaknesses of peptide drugs. The second section contains five cases studies of peptides from diverse therapeutic fields, and the lessons to be learned from them, while the final part looks at new targets and opportunities, discussing several drug targets and diseases for which peptide drugs are currently being developed.